Zevra Therapeutics
Matthew Pitino is a Financial Planning and Analysis Associate at Zevra Therapeutics since March 2023, where responsibilities include consolidating and analyzing KPIs and financial reporting for the executive committee, as well as building budgets and conducting quarterly reviews. Prior to this role, Matthew worked as a Staff Accountant at NEOGOV, handling vendor management, accounts payable, and financial reconciliations. Matthew also served as an Accounting Assistant at PowerDMS by NEOGOV, performing similar tasks and managing corporate credit cards. Earlier experience includes an Accounting Intern position at KemPharm, Inc., focusing on internal control testing, and as a Bookkeeper at Ronnie Pitino CPA PA, providing accounting services and payroll management. Matthew holds a Bachelor of Science in Business Administration with a focus in Accounting from the University of Central Florida, graduating in 2022.
Zevra Therapeutics
1 followers
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies. With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients. Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.